Most Recent

image: Commander of an Immune Flotilla

Commander of an Immune Flotilla

By | April 1, 2014

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

1 Comment

image: Contributors

Contributors

By | April 1, 2014

Meet some of the people featured in the April 2014 issue of The Scientist.

0 Comments

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: Future Minded

Future Minded

By | April 1, 2014

Imagine consciousness traveling at the speed of light.

2 Comments

image: Search and Destroy

Search and Destroy

By | April 1, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2014

April 2014's selection of notable quotes

2 Comments

image: Metals on our Mind

Metals on our Mind

By | April 1, 2014

A dramatic loss of copper in key brain regions may be central to Alzheimer’s disease. Could restoring metals in the brain help?

4 Comments

image: Overcoming Resistance

Overcoming Resistance

By | April 1, 2014

In the face of bacterial threats that can evade modern medicines, researchers are trying every trick in the book to develop new, effective antibiotics.

4 Comments

image: Oxytocin Boosts Dishonesty

Oxytocin Boosts Dishonesty

By | March 31, 2014

The so-called “love hormone” can make people more dishonest when it serves the interests of their group. 

4 Comments

image: Ballroom Brainwaves

Ballroom Brainwaves

By | March 28, 2014

A neuroscientist studies the brains of tango dancers in an attempt to understand interpersonal connectedness.

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham